Characterization of Brain Lysosomal Activities in GBA-Related and Sporadic Parkinson's Disease and Dementia with Lewy Bodies
Top Cited Papers
Open Access
- 31 January 2019
- journal article
- research article
- Published by Springer Science and Business Media LLC in Molecular Neurobiology
- Vol. 56 (2), 1344-1355
- https://doi.org/10.1007/s12035-018-1090-0
Abstract
Mutations in the GBA gene, encoding the lysosomal hydrolase glucocerebrosidase (GCase), are the most common known genetic risk factor for Parkinson's disease (PD) and dementia with Lewy bodies (DLB). The present study aims to gain more insight into changes in lysosomal activity in different brain regions of sporadic PD and DLB patients, screened for GBA variants. Enzymatic activities of GCase, -hexosaminidase, and cathepsin D were measured in the frontal cortex, putamen, and substantia nigra (SN) of a cohort of patients with advanced PD and DLB as well as age-matched non-demented controls (n=15/group) using fluorometric assays. Decreased activity of GCase (-21%) and of cathepsin D (-15%) was found in the SN and frontal cortex of patients with PD and DLB compared to controls, respectively. Population stratification was applied based on GBA genotype, showing substantially lower GCase activity (similar to-40%) in GBA variant carriers in all regions. GCase activity was further significantly decreased in the SN of PD and DLB patients without GBA variants in comparison to controls without GBA variants. Our results show decreased GCase activity in brains of PD and DLB patients with and without GBA variants, most pronounced in the SN. The results of our study confirm findings from previous studies, suggesting a role for GCase in GBA-associated as well as sporadic PD and DLB.Keywords
Funding Information
- F. Hoffmann-La Roche
- Stichting ParkinsonFonds
- Fondazione Cassa di Risparmio di Perugia
This publication has 57 references indexed in Scilit:
- Glucocerebrosidase Mutations alter the endoplasmic reticulum and lysosomes in Lewy body diseaseJournal of Neurochemistry, 2012
- Glucocerebrosidase deficiency in substantia nigra of parkinson disease brainsAnnals of Neurology, 2012
- Meta‐analysis of Parkinson's Disease: Identification of a novel locus, RIT2Annals of Neurology, 2011
- Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's DiseaseThe New England Journal of Medicine, 2009
- Cathepsin D expression level affects alpha-synuclein processing, aggregation, and toxicity in vivoMolecular Brain, 2009
- Lysosomal enzyme cathepsin D protects against alpha-synuclein aggregation and toxicityMolecular Brain, 2008
- Cathepsin D Is the Main Lysosomal Enzyme Involved in the Degradation of α-Synuclein and Generation of Its Carboxy-Terminally Truncated SpeciesBiochemistry, 2008
- Oxidative stress‐induced phosphorylation, degradation and aggregation of α‐synuclein are linked to upregulated CK2 and cathepsin DEuropean Journal of Neuroscience, 2007
- A new mathematical model for relative quantification in real-time RT-PCRNucleic Acids Research, 2001
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976